Duncan Williams Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$906K Hold
7,052
0.2% 67
2026
Q1
$848K Sell
7,052
-222
-3% -$25.6K 0.24% 65
2025
Q4
$861K Sell
7,274
-42
-0.6% -$3.94K 0.21% 71
2025
Q3
$614K Buy
7,316
+90
+1% +$7.41K 0.17% 86
2025
Q2
$572K Sell
7,226
-55
-0.8% -$4.37K 0.18% 85
2025
Q1
$654K Sell
7,281
-375
-5% -$35K 0.24% 70
2024
Q4
$762K Buy
7,656
+3,045
+66% +$314K 0.3% 59
2024
Q3
$524K Buy
+4,611
New +$548K 0.29% 70
2024
Q2
Sell
-2,519
Closed -$332K 68
2024
Q1
$332K Buy
+2,519
New +$310K 0.3% 52

Other funds holding MRK

Duncan Williams Asset Management's MRK Position: Q2 2026 in Review

Duncan Williams Asset Management held its Merck (MRK) position steady in Q2 2026 at 7,052 shares worth $906K. The position accounts for 0.2% of the portfolio, ranked #67.

Duncan Williams Asset Management first reported a position in MRK in Q1 2024 and has held it in 9 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Duncan Williams Asset Management held 7,052 shares of Merck worth $906K as of Q2 2026.
  • Duncan Williams Asset Management left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.2% of Duncan Williams Asset Management's portfolio in Q2 2026, its #67 holding.
  • Duncan Williams Asset Management first reported a position in Merck in Q1 2024 and has held it in 9 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Duncan Williams Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.